BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsai HL, Yang IP, Lin CH, Chai CY, Huang YH, Chen CF, Hou MF, Kuo CH, Juo SH, Wang JY. Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. Int J Colorectal Dis. 2013;28:415-424. [PMID: 22961433 DOI: 10.1007/s00384-012-1570-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 De Campos CB, Damasceno KA, Gamba CO, Ribeiro AM, Machado CJ, Lavalle GE, Cassali GD. Evaluation of prognostic factors and survival rates in malignant feline mammary gland neoplasms. Journal of Feline Medicine and Surgery 2016;18:1003-12. [DOI: 10.1177/1098612x15610367] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Huang MY, Tsai HL, Huang JJ, Wang JY. Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer. Transl Oncol 2016;9:340-7. [PMID: 27567958 DOI: 10.1016/j.tranon.2016.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lai E, Cascinu S, Scartozzi M. Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. Front Oncol 2021;11:637823. [PMID: 34041019 DOI: 10.3389/fonc.2021.637823] [Reference Citation Analysis]
4 Yang IP, Tsai HL, Miao ZF, Huang CW, Kuo CH, Wu JY, Wang WM, Juo SH, Wang JY. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients. J Transl Med. 2016;14:108. [PMID: 27126129 DOI: 10.1186/s12967-016-0856-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
5 Babiker AY, Almatroodi SA, Almatroudi A, Alrumaihi F, Abdalaziz MS, Alsahli MA, Husain Rahmani A. Clinicopathological significance of VEGF and pAkt expressions in oral squamous cell carcinoma. All Life 2020;13:507-15. [DOI: 10.1080/26895293.2020.1815595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Tsai HL, Huang CW, Yeh YS, Ma CJ, Chen CW, Lu CY, Huang MY, Yang IP, Wang JY. Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients: a retrospective single institution cohort study of 1167 consecutive patients. BMC Surg 2016;16:17. [PMID: 27079509 DOI: 10.1186/s12893-016-0132-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
7 Dai W, Li Y, Mo S, Feng Y, Zhang L, Xu Y, Li Q, Cai G. A robust gene signature for the prediction of early relapse in stage I-III colon cancer. Mol Oncol 2018;12:463-75. [PMID: 29377588 DOI: 10.1002/1878-0261.12175] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
8 Tsai H, Huang C, Chen C, Yeh Y, Ma C, Wang J. Survival in Resected Stage II Colorectal Cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative CEA Level, and The Number of Examined Lymph Nodes. World J Surg 2016;40:1002-9. [DOI: 10.1007/s00268-015-3331-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
9 Deng X, Liu M, Sun J, Li M, Liu D, Li L, Fang J, Wang X, Zhang J. Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancer. Eur J Radiol 2021;134:109429. [PMID: 33290975 DOI: 10.1016/j.ejrad.2020.109429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lou YT, Chen CW, Fan YC, Chang WC, Lu CY, Wu IC, Hsu WH, Huang CW, Wang JY. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy. PLoS One 2014;10:e0123973. [PMID: 25919688 DOI: 10.1371/journal.pone.0123973] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
11 Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1214. [PMID: 32413973 DOI: 10.3390/cancers12051214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
12 Tsai HL, Miao ZF, Chen YT, Huang CW, Yeh YS, Yang IP, Wang JY. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions. J Cell Mol Med 2019;23:3572-82. [PMID: 30834693 DOI: 10.1111/jcmm.14257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kong XQ, Huang YX, Li JL, Zhang XQ, Peng QQ, Tang LR, Wu JX. Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer. World J Gastrointest Oncol 2018; 10(10): 351-359 [PMID: 30364886 DOI: 10.4251/wjgo.v10.i10.351] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Tsai H, Yang I, Huang C, Ma C, Kuo C, Lu C, Juo S, Wang J. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Translational Research 2013;162:258-68. [DOI: 10.1016/j.trsl.2013.07.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
15 Xu B, Yu L, Zhao LZ, Ma DW. Prognostic factors in the patients with T2N0M0 colorectal cancer. World J Surg Oncol 2016;14:76. [PMID: 26965721 DOI: 10.1186/s12957-016-0826-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
16 Ortiz-morales MJ, Toledano-fonseca M, Mena-osuna R, Cano MT, Gómez-españa A, Haba-rodríguez JRDL, Rodríguez-ariza A, Aranda E. Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab. Cancers 2022;14:3054. [DOI: 10.3390/cancers14133054] [Reference Citation Analysis]
17 Zhang J, Liu J, Zhu C, He J, Chen J, Liang Y, Yang F, Wu X, Ma X. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis. Oncotarget 2017;8:24797-803. [PMID: 28177889 DOI: 10.18632/oncotarget.15044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
18 Kampoli K, Foukas PG, Ntavatzikos A, Arkadopoulos N, Koumarianou A. Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer. World J Methodol 2022; 12(1): 43-53 [DOI: 10.5662/wjm.v12.i1.43] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dai W, Feng Y, Mo S, Xiang W, Li Q, Wang R, Xu Y, Cai G. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer. Carcinogenesis 2018;39:1235-44. [PMID: 29982331 DOI: 10.1093/carcin/bgy087] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
20 Goulart A, Ferreira C, Rodrigues A, Coimbra B, Sousa N, Leão P. The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer. Ann Surg Treat Res 2019;97:15-20. [PMID: 31297348 DOI: 10.4174/astr.2019.97.1.15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
21 Wong SCC, Cheung MT, Luk LLY, Lee VHM, Chan PT, Tsang HFA, Wong EYK, Xue VW, Chan AKC, Chan JKC. Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients. Oncotarget 2018;9:6737-51. [PMID: 29467924 DOI: 10.18632/oncotarget.23424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Wu K, Yi Y, Liu F, Wu W, Chen Y, Zhang W. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis. Oncol Lett 2018;16:1003-9. [PMID: 29963176 DOI: 10.3892/ol.2018.8768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]